Chlamydia

For the second year in a row, the CDC’s annual STI report showed an overall decline in combined cases of the three nationally reportable infections — chlamydia, gonorrhea and syphilis.

NEW YORK — In this video, Jacob R. McLean, DO, assistant professor of medicine at Columbia University, recaps his presentation on adolescent STI screening and treatment at the Infectious Diseases in Children Symposium.

Although reported cases remain high, there are signs the STI epidemic in the United States is slowing after years of record numbers, the CDC said Tuesday.

Less than 3% of patients tested for a bacterial STI in nearly a dozen EDs were also tested for HIV, demonstrating widespread nonadherence to a CDC recommendation, according to a study presented at IDWeek.

Testing HIV PrEP users for STIs every 6 months did not increase the risk for STIs compared with testing them every 3 months and could reduce the cost of PrEP programs, according to a study.

In the past decade, STDs have increased among women aged at least 55 years, highlighting the importance of discussing sexual partners, sexual history and condom use with all patients, regardless of age.

Reported cases of gonorrhea in the United States declined for the first time in at least a decade in 2022 while cases of chlamydia remained stagnant and syphilis continued its years-long surge, data released by the CDC on Tuesday showed.

In the United States, there were approximately 1.6 million cases of chlamydia, 710,000 cases of gonorrhea and 176,000 cases of syphilis reported in 2021, according to the CDC.

Prior infections with chlamydia and/or gonorrhea were common among people diagnosed with mpox, according to data gathered and assessed by the Chicago Department of Public Health.

BOSTON — In this video from IDWeek, Annie Luetkemeyer, MD, discusses the CDC’s pending recommendations for prescribing doxycycline as post-exposure prophylaxis for sexually transmitted infections.